Top Markets
#1 Prom Prom +36.01%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +27.85%
#4 UnifAI Network UnifAI Network +23.33%
#5 Tutorial Tutorial +19.31%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +18.53%
#7 Pons Pons +17.42%
#8 Versatize Coin Versatize Coin +16.65%
#9 Derive Derive +13.93%
#10 GEKKO GEKKO +13.35%
Coin of the day
Prom Prom
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classificação em ações #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Preço da ação
$20.38
Valor de mercado
$129.09M
Variação (1 dia)
-0.82%
Variação (1 ano)
80.91%
País
PL
Negociar Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Healthcare
Lucros da Captor Therapeutics Spolka Akcyjna (CTX)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Captor Therapeutics Spolka Akcyjna, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Captor Therapeutics Spolka Akcyjna de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH